In the third quarter, we reported core earnings of $442 million or $1.26 per diluted share; 8% growth in year-over-year diluted book value per share, excluding AOCI; and a trailing 12-month core earnings ROE of 12.5%.
We returned $634 million to shareholders in the quarter from share repurchases and common dividends and $1.6 billion for the nine months ended September 30.
The confidence we have in our business is also evidenced by the announcement that we have increased our share repurchase program by $500 million, bringing the total authorization to $3 billion through the end of 2022.
And we increased our quarterly dividend by 10%, payable in January of 2022.
Commercial Lines reported stellar margins with an industry-leading 87.2 underlying combined ratio and another double-digit top line growth, reflecting higher new business levels, continued strong retention and solid renewal price increases.
Through a modernized platform, in partnership with AARP, one of the largest affinity groups in America, we see the opportunity to capitalize on the growth in the mature market segment as this demographic is expected to grow 3 times as fast as the rest of the U.S. population over the next decade.
Core earnings for the quarter were $19 million, reflecting elevated life and short-term disability claims, partially offset by strong investment returns, improved long-term disability results and earned premium growth.
Fully insured ongoing premium is up 4%.
Persistency was above 90% and increased approximately one point over prior year.
As of this week, U.S. COVID deaths for the third quarter now exceed 112,000, and this number is likely to continue to increase in the weeks ahead due to reporting lags in the data.
Additionally, the mortality experience from the Delta surge has a higher percentage impact on the under 65 population compared to prior periods.
Approximately 40% of U.S.-reported COVID deaths in August and September were of individuals under age 65 compared to approximately 20% of COVID deaths in December of 2020 and January of 2021.
In addition, we experienced higher levels of non-COVID excess mortality during the quarter, representing approximately 30% of reported excess mortality loss.
Core earnings for the quarter of $442 million or $1.26 per diluted share reflects excellent investment results with a 40% annualized return on limited partnership investments and continued strong underlying results, offset by $300 million of catastrophe losses with $200 million from Hurricane Ida and excess mortality of $212 million in Group Benefits.
In P&C, the underlying combined ratio of 88.3 improved 2.3 points from the third quarter of 2020, highlighted by excellent performance in our Commercial Lines segment.
In Commercial Lines, we produced an underlying combined ratio of 87.2, a 6.5-point improvement from the third quarter of 2020, and 15% written premium growth for the second consecutive quarter.
In Personal Lines, an underlying combined ratio of 91.8 compares to 81.4 in the prior year quarter, which reflects higher auto claim frequency from increased miles driven and higher severity.
P&C prior accident year reserve development within core earnings was a net unfavorable $62 million, driven by the new settlement agreement with BSA, partially offset by reserve reductions of $75 million, including decreases in workers' compensation, personal auto liability, package business and bond.
In the quarter, we ceded an additional $28 million of Navigators reserves to the adverse development cover primarily related to wholesale construction.
Group Benefits core earnings of $19 million decreased from $116 million in third quarter 2020, largely driven by higher excess mortality losses in group life, partially offset by increase in net investment income.
All-cause excess mortality in the quarter was $212 million before tax, which includes $233 million for third quarter deaths, offset by $21 million of net favorable development from prior periods, predominantly from the second quarter of 2021.
The percentage of excess mortality not specifically attributed to a COVID-19 cause of loss is more significant this quarter than it has been in the past and represents approximately 30% of the total.
Excluding losses from short-term disability related to COVID-19 and excess mortality, the core earnings margin was 12.6%.
The disability loss ratio in this year's quarter was 3.1 points higher as the prior year loss ratio benefited from favorable short-term disability claim frequency due to fewer elective medical procedures during the early stages of the pandemic.
The program delivered $306 million in pre-tax expense savings in the nine months ended September 30, 2021, compared to the same period in 2019.
We continue to expect full year pre-tax savings of approximately $540 million in 2022 and $625 million in 2023.
Core earnings for the quarter were $58 million compared with $40 million for the prior year period, reflecting the impact of daily average AUM increasing 27%.
Total AUM at September 30 was $152 billion.
Mutual fund net inflows were approximately $300 million compared with net outflows of $1.3 billion in third quarter 2020.
As a low-capital business, its return on equity has been outstanding, consistently over 45% since 2018.
The Corporate core loss was lower at $47 million compared to a loss of $57 million in the prior year quarter, primarily due to a $21 million before tax loss in third quarter 2020 from the equity interest in Talcott Resolution, which was sold earlier in 2021.
Net investment income was $650 million, up 32% from the prior year quarter, benefiting from very strong annualized limited partnership returns of 40%, driven by higher valuations and cash distributions within private equity funds and sales of underlying investments in real estate.
The total annualized portfolio yield, excluding limited partnerships, was 3% before tax compared to 3.3% in the third quarter of 2020, reflecting the lower interest rate environment.
Net unrealized gains on fixed maturities before tax were $2.5 billion at September 30, down from $2.8 billion at June 30 due to higher interest rates and wider credit spreads.
Book value per diluted share, excluding AOCI, rose 8% since September 30, 2020, to $49.64, and our trailing 12-month core earnings ROE was 12.5%.
During the quarter, The Hartford returned $634 million to shareholders, including $511 million of share repurchases and $123 million in common dividends paid.
Yesterday, the Board approved a 10% increase in the common dividend and increased our share repurchase authorization by $500 million.
With this increase and the $1.2 billion of repurchases completed through September 30, there remains $1.8 billion of share repurchase authorization in effect through 2022.
From October one through October 27, we repurchased approximately 1.5 million common shares for $108 million.
Cash and investments at the holding company were $2.1 billion as of September 30, which includes the proceeds from the September issuance of $600 million of 2.9% senior notes.
These proceeds will be used to repay our $600 million 7.875% junior subordinated debentures, which are redeemable at par on or after April 15, 2022.
During the third quarter, we received $443 million in dividends from subsidiaries and expect approximately $445 million in the fourth quarter.
In the quarter, the underlying combined ratio was an outstanding 88.3.
As Beth mentioned, Commercial Lines produced a terrific underlying combined ratio of 87.2, with over five points of improvement coming from the loss ratio and another point from expenses.
Small Commercial written premium of just over $1 billion was a third quarter record, increasing 14% over prior year.
Policy count retention was strong at 84%, and in-force policies grew 6% versus prior year.
Small Commercial new business of $165 million was up 28%, the fourth consecutive quarter of double-digit growth.
In Middle & Large Commercial, we produced a second consecutive excellent quarter with written premium growth of 18%.
Middle Market new business of $139 million was up 6% in the quarter driven in large part by our industry verticals.
Policy retention increased 8% -- or eight points to 87%, one of the strongest retention quarters in quite some time.
Global Specialty produced another strong quarter with written premium growth of 14%.
New business growth of 26% was equally impressive, and retention remains strong in the mid-80s.
In the quarter, the breadth of our written premium growth was led by 14% in wholesale and 19% in U.S. financial lines.
Global Reinsurance also had an excellent quarter with written premium growth of 39%.
As a proof point, third quarter cross-sell new business premium between Global Specialty and Middle & Large Commercial was $15 million.
With this result, we have now exceeded our initial transaction goal of $200 million, more than a year early.
U.S. Standard Commercial Lines pricing, excluding workers' compensation, was 6.5%, consistent with the second quarter.
Middle Market ex workers' compensation price change of 8.1% was essentially flat to quarter two and continues to exceed loss cost trend.
In Standard Commercial workers' compensation, renewal written pricing was in line with quarter two at 1.2%.
Global Specialty renewal written price remained strong in the U.S. at 10% and international at 17%.
The third quarter underlying combined ratio rose 10.4 points to 91.8.
Written premium declined 2%.
Policy retention was relatively stable at 84%, and new business premium was up 6% in the quarter.
This new business uptick occurred despite J.D. Power's survey results concluding that auto insurance shopping rates among the 50-plus age segment remains 6% below a year ago.
The Prevail product will be in two more states over the next 90 days.
